We use labs, health history, and honest conversations about what each medication can and cannot do to build plans that fit real people
Cardiovascular and Liver Benefits : Preliminary data suggest potential reductions in liver fat and improvements in cardiovascular markers, though further research is needed
Reference information: J Clin Invest
No research demonstrates that GLP-1 medications reduce thyroid antibody levels, slow autoimmune thyroid destruction, or improve thyroid function in patients with Hashimoto's disease
While long-term safety data continue to emerge, early clinical trials published in the England Journal of Medicine and other peer-reviewed outlets demonstrate sustained weight reduction, improved metabolic health, and durable blood pressure and blood sugar control
Thus, NMN transporter expression, microbiota composition, and NAD + metabolism in multiple organs in INKO mice should be further explored